UnitedHealth Group (UNH), a health care and well-being company, reported first-quarter 2026 results, reflecting 2% in revenue growth. In addition, the firm raised the full-year 2026 adjusted earnings guidance.
Following the news, UNH is currently surging 9.42% to $353.96.
Net earnings attributable to UnitedHealth Group common shareholders slipped to $6.28 billion from $6.29 billion in the prior year.
Meanwhile, adjusted earnings per share increased to $7.23 from $7.20 a year ago.
Net earnings increased to $6.48 billion or $6.90 per share from $6.47 billion or $6.85 per share in the prior year.
Revenue increased to $111.72 billion compared to $109.58 billion in the year ago.
Looking ahead, the company now expects full-year 2026 adjusted net earnings to exceed $18.25 per share, up from earlier expectations of more than $17.75 per share.
UnitedHealth Group operates through four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare.
"We are continuing to help simplify and modernise health care for the people and care providers we serve, bringing greater value, affordability, transparency and connectivity," said Stephen Hemsley, chief executive officer of UnitedHealth Group.
UNH has traded between $234.60 and $438.85 over the last year. The stock closed Monday's trading at $323.48.
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.